These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 6384650)

  • 61. Amelioration of hyperchloremic acidosis with furosemide therapy in patients with chronic renal insufficiency and type 4 renal tubular acidosis.
    Sebastian A; Schambelan M; Sutton JM
    Am J Nephrol; 1984; 4(5):287-300. PubMed ID: 6524600
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Selective hypoaldosteronism in a patient with Sjögren's syndrome: insensitivity to angiotensin II.
    Otabe S; Muto S; Asano Y; Ohbu E; Koyama K; Okita N; Yamada K; Nonaka K
    Nephron; 1991; 59(3):466-70. PubMed ID: 1758539
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The enigma of pseudohypoaldosteronism.
    Zennaro MC; Borensztein P; Soubrier F; Armanini D; Corvol P
    Steroids; 1994 Feb; 59(2):96-9. PubMed ID: 8191555
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Distal tubular acidosis. Recent data].
    Paillard M; Houillier P; Borensztein P; Prigent A
    Nephrologie; 1991; 12(3):125-30. PubMed ID: 1656291
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Adult nephron-specific MR-deficient mice develop a severe renal PHA-1 phenotype.
    Canonica J; Sergi C; Maillard M; Klusonova P; Odermatt A; Koesters R; Loffing-Cueni D; Loffing J; Rossier B; Frateschi S; Hummler E
    Pflugers Arch; 2016 May; 468(5):895-908. PubMed ID: 26762397
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hyperkalemia due to hyporeninemic hypoaldosteronism with liver cirrhosis and hypertension.
    Kee CS; Choi JW; Chang DK; Ahn YH; Kim HJ
    J Korean Med Sci; 1993 Dec; 8(6):464-70. PubMed ID: 8179835
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Transient pseudo-hypoaldosteronism following resection of the ileum: normal level of lymphocytic aldosterone receptors outside the acute phase.
    Vantyghem MC; Hober C; Evrard A; Ghulam A; Lescut D; Racadot A; Triboulet JP; Armanini D; Lefebvre J
    J Endocrinol Invest; 1999 Feb; 22(2):122-7. PubMed ID: 10195379
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Na(+), K(+), Cl(-), acid-base or H2O homeostasis in children with urinary tract infections: a narrative review.
    Bertini A; Milani GP; Simonetti GD; Fossali EF; Faré PB; Bianchetti MG; Lava SA
    Pediatr Nephrol; 2016 Sep; 31(9):1403-9. PubMed ID: 26701834
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hyporeninemic hypoaldosteronism, sodium wasting and mineralocorticoid-resistant hyperkalemia in two patients with obstructive uropathy.
    Pelleya R; Oster JR; Perez GO
    Am J Nephrol; 1983; 3(4):223-7. PubMed ID: 6351617
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Molecular genetic studies in a case series of isolated hypoaldosteronism due to biosynthesis defects or aldosterone resistance.
    Turan I; Kotan LD; Tastan M; Gurbuz F; Topaloglu AK; Yuksel B
    Clin Endocrinol (Oxf); 2018 Jun; 88(6):799-805. PubMed ID: 29582446
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prospective diagnosis of pseudohypoaldosteronism.
    Schindler AM; Bergman GE
    Pediatrics; 1986 Sep; 78(3):516-8. PubMed ID: 3529026
    [No Abstract]   [Full Text] [Related]  

  • 72. Hyperkalemia in type 4 renal tubular acidosis associated with systemic lupus erythematosus.
    Üsküdar Cansu D; Cansu GB; Güvenir S; Korkmaz C
    Rheumatol Int; 2020 Nov; 40(11):1895-1901. PubMed ID: 32166438
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Hyporeninemic hypoaldosteronism. Case report and attempt at pathophysiological classification (author's transl)].
    Cuervas-Mons V; Moya Mir MS; Martín Martín F; Barbadillo García de Velasco R; Sánchez Miró I; Martín Jiménez T; Lorenz Pérez P
    Med Clin (Barc); 1980 Nov; 75(8):342-5. PubMed ID: 7003270
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hyporeninemic hypoaldosteronism associated with acquired immune deficiency syndrome.
    Kalin MF; Poretsky L; Seres DS; Zumoff B
    Am J Med; 1987 May; 82(5):1035-8. PubMed ID: 3555065
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical manifestations and associated factors in acquired hypoaldosteronism in endocrinological practice.
    Ruiz-Sánchez JG; Calle-Pascual AL; Rubio-Herrera MÁ; De Miguel Novoa MP; Gómez-Hoyos E; Runkle I
    Front Endocrinol (Lausanne); 2022; 13():990148. PubMed ID: 36303866
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Selective hypoaldosteronism with hyperreninemia in a diabetic patient.
    Morimoto S; Kim KS; Yamamoto I; Uchida K; Takeda R; Kornel L
    J Clin Endocrinol Metab; 1979 Nov; 49(5):742-7. PubMed ID: 489714
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pseudohypoaldosteronism with pyloric stenosis--a patient report.
    Wang YM
    J Pediatr Endocrinol Metab; 1997; 10(4):429-31. PubMed ID: 9364371
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Salt wasting, raised plasma-renin activity, and normal or high plasma-aldosterone: a form of pseudohypoaldosteronism.
    Rösler A; Theodor R; Gazit E; Biochis H; Rabinowitz D
    Lancet; 1973 May; 1(7810):959-62. PubMed ID: 4121586
    [No Abstract]   [Full Text] [Related]  

  • 79. Hyper- and hypoaldosteronism.
    Torpy DJ; Stratakis CA; Chrousos GP
    Vitam Horm; 1999; 57():177-216. PubMed ID: 10232050
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prevalence, pathogenesis, and functional significance of aldosterone deficiency in hyperkalemic patients with chronic renal insufficiency.
    Schambelan M; Sebastian A; Biglieri EG
    Kidney Int; 1980 Jan; 17(1):89-101. PubMed ID: 6990090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.